Colombia vs Maldives: Cause of death, by non-communicable diseases, ages 0-4
Colombia
35.2%
in 2021
Maldives
35.3%
in 2021
Colombia rank
73rd
Maldives rank
71st
Cause of death, by non-communicable diseases, ages 0-4 over time
- Colombia
- Maldives
How they compare
Maldives currently reports 35.3% against 35.2% in Colombia, a difference of 0.1%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Colombia ahead.
Colombia ranks 73rd and Maldives ranks 71st of 185 countries.
Across the 3 decades both report, Colombia averaged higher in 1 and Maldives in 2.
Head to head by decade
| Decade | Colombia | Maldives | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 22.7% | 16.6% | 6.1% | Colombia |
| 2010s | 34.5% | 35.8% | 1.3% | Maldives |
| 2020s | 34.9% | 35.6% | 0.7% | Maldives |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, Colombia or Maldives?
- Maldives, at 35.3% against 35.2% in Colombia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4 between Colombia and Maldives?
- 0.1%, with Maldives ahead.
- How many years of comparable data are there for Colombia and Maldives?
- 6 years are reported by both, from 2000 to 2021.
- How do Colombia and Maldives rank globally for cause of death, by non-communicable diseases, ages 0-4?
- Colombia ranks 73rd and Maldives ranks 71st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4 (% of total deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 0-4 due to non-communicable diseases divided by number of all deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.